BioSpace News Archive

Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is pleased to announce that it has closed the merger with BIOCOGENCY LABORATORIES. The new consolidated financials will include Slavich ( http://www.slavich.ru ), Slavich Trading House and related companies based in Spain, Ireland and Cyprus, with Kras Pharma ( http://kraspharma.ru ) and Bebig ( http://en.bebig.ru /) being added in due course. The company’s Slovenian assets will be divested, p

PRF-110 addresses potential concerns in the local administration of anesthetic related to wound healing and suture integrity that are commonly involved in surgical procedures

Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., today announced it will begin its donor study as a precursor for its FDA EUA, EU CE Mark and Russian Federation testing of its Genviro! Saliva Swift Kit for the detection of Covid-19.

Plexision, ( www.plexision.com ) a biotech company specializing in cell-based technologies, has been awarded a National Science Foundation (NSF) Phase 1 Small Business Innovation Research grant. This funding will be used to develop a widely available version of Plexision’s novel immunity test for COVID-19 infection. Current tests assess protect

Chemomab Ltd., a clinical-stage biotech company focusing on discovery and development of innovative therapeutics for fibrosis-related diseases, today announces that clinical data from its phase Ib study of CM-101 in non-alcoholic fatty liver disease (NAFLD) patients will be presented as a late-breaking poster presentation at The Liver Meeting Digital Experience™ 2020

Bioness, Inc., the leading provider of cutting-edge, clinically supported rehabilitation therapies, today announced the commercial launch of the new Bioness Integrated Therapy System (BITS) for Balance.

Rare disease therapy. One-time gene therapies. High-priced cancer drugs. These are all reasons why a consumer may have drug costs of $250,000 or more annually.

Citizens United for Research in Epilepsy (CURE), the private non-profit leader laser-focused on finding a cure for epilepsy, today announced the organization’s rebrand to CURE Epilepsy.

Reproductive Medicine Associates of New Jersey (RMA New Jersey), world-renowned leaders in the field of infertility treatment and research, will present over 30 clinical abstracts at the ASRM 2020 meeting including data from the PROV-ET Trial which investigated the predictive value of an aneuploid diagnosis with PGT-A

BioForward Wisconsin, the collective voice of Wisconsin’s robust and comprehensive biohealth cluster representing more than 220 member organizations, reflected the resilience of the Wisconsin biohealth industry through its annual Wisconsin Biohealth Summit, held virtually for three days in September and October.